714 search results for “development disease” in the Staff website
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
Michael Richardsonm.k.richardson@biology.leidenuniv.nl | 071 5275215
-
Leiden researchers pioneer ‘green’ framework for sustainable drug development
Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and Justin Lian have developed a framework to help the healthcare system assess the economic and environmental sustainability of medical compounds.
-
Micha Drukkerm.drukker@lacdr.leidenuniv.nl | 071 5276271
-
Martijn van der Liendenm.j.c.van.der.lienden@lic.leidenuniv.nl | 071 5272727
-
How cells determine the fate of proteins (and can we do it too?)
Cells in our bodies are often threatened by errors in our own proteins. The FLOW consortium, comprising scientists from various institutions including Leiden, is poised to meticulously map out for the first time how cells control proteins, correcting or removing faulty ones. This endeavour holds promise…
-
LUMC signs international agreement on developing Advanced Therapy Medicinal Products
Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…
-
Berna GürogluFaculty of Social and Behavioural Sciences
bguroglu@fsw.leidenuniv.nl | 071 5272727
-
New platform to accelerate cardiac drug development
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac microtissues. This platform will allow large numbers of drugs to be tested quickly
-
Janna Marie Bas-HoogendamFaculty of Social and Behavioural Sciences
j.m.hoogendam@fsw.leidenuniv.nl | 071 5276345
-
Somayah Elsayeds.elsayed@biology.leidenuniv.nl | 071 5271886
-
Jonathan PhillipsFaculty of Social and Behavioural Sciences
j.p.phillips@fsw.leidenuniv.nl | 071 5272727
-
Alette VonkFaculty of Humanities
a.p.vonk@hum.leidenuniv.nl | 071 5272746
-
Paul van den BroekFaculty of Social and Behavioural Sciences
p.vandenbroek@fsw.leidenuniv.nl | 071 5272727
-
Ayokunu AdedokunFaculteit Governance and Global Affairs
a.b.adedokun@luc.leidenuniv.nl | 070 8009503
-
Chris RiddellFaculty of Social and Behavioural Sciences
c.d.riddell@fsw.leidenuniv.nl | 071 5272727
-
Virgil Urbina Lazardi
Faculty of Social and Behavioural Sciences
v.urbina.lazardi@fsw.leidenuniv.nl |
-
Agnieszka KazimierczukAfrika-Studiecentrum
a.h.kazimierczuk@asc.leidenuniv.nl | 071 5272727
-
Leiden students develop highly contagious card game
Infecting each other with viruses and bacteria while protecting yourself with medicines and vaccinations. Sounds like a fun evening, right? Master students Life Science & Technology Rafael Jezior and Dennis de Beeld certainly think so. Together, they developed ImmunoWars: an exciting card game based…
-
Sophie van RijnFaculty of Social and Behavioural Sciences
srijn@fsw.leidenuniv.nl | 071 5272727
-
Jan Michiel OttoFaculteit der Rechtsgeleerdheid
j.m.otto@law.leidenuniv.nl | 071 5277260
-
LUMC receives tens of millions for research into new stem cell-based treatments
Leiden University Medical Center (LUMC), as a partner in the reNEW consortium, is once again receiving tens of millions of euros for research into new treatments based on stem cells. The collaboration will receive a total of €150 million to develop new therapies in regenerative medicine.
-
PhD candidate develops new device for diagnosing erectile dysfunction
Erection problems can have a huge impact on quality of life and health, but current diagnostic methods are painful, uncomfortable and technologically outdated. PhD candidate Evelien Trip has developed a new device that can measure erections more comfortably and painlessly.
-
Nienke BouwFaculty of Social and Behavioural Sciences
j.c.bouw@fsw.leidenuniv.nl | 071 5272727
-
Horst FischerFaculteit der Rechtsgeleerdheid
h.fischer@law.leidenuniv.nl | 071 5272727
-
Bert KoendersFaculteit Governance and Global Affairs
a.g.koenders@fgga.leidenuniv.nl | 070 8009500
-
Josien de KlerkFaculteit Governance and Global Affairs
j.de.klerk@luc.leidenuniv.nl | 070 8009557
-
Daniëlla Dam-de JongFaculteit der Rechtsgeleerdheid
d.a.dam@law.leidenuniv.nl | 071 5277944
-
Emilie PrastFaculty of Social and Behavioural Sciences
e.j.prast@fsw.leidenuniv.nl | 071 5272727
-
Christian HendersonFaculty of Humanities
c.j.v.henderson@hum.leidenuniv.nl | 071 5274995
-
Catherine WoodFaculty of Humanities
c.m.wood@hum.leidenuniv.nl | 071 5277177
-
Hauke Wardh.ward@cml.leidenuniv.nl | 071 5276808
-
Antonella MaielloFaculteit Governance and Global Affairs
a.maiello@fgga.leidenuniv.nl | 070 8009991
-
Tejaswini SharmaFaculty of Social and Behavioural Sciences
t.sharma@fsw.leidenuniv.nl |
-
‘Ultimately, the goal is to develop antibiotics for tuberculosis with a lower risk of resistance’
Tuberculosis stands as one of the most lethal infectious diseases worldwide. A significant challenge in combatting tuberculosis lies in the emergence of antibiotic resistance triggered by genetic alterations, commonly known as mutations. These mutations can diminish the responsiveness to antibiotics,…
-
Mini organs-on-chips: an alternative to drug testing on animals
Mini organs-on-chips allow us to study how diseases develop and how drugs work. Although the technology is not new, it is becoming increasingly advanced. PhD candidate Bart Kramer hopes it will eliminate animal testing in the future.
-
Chao Duc.du@biology.leidenuniv.nl | 071 5274947
-
Joost Willemsejwillemse@biology.leidenuniv.nl | 071 5274986
-
Caro AalderinkFaculty of Social and Behavioural Sciences
c.aalderink@fsw.leidenuniv.nl |
- Kim Molenaar
-
Blueprints of Disease: Precision Platforms for Modelling Breast Cancer
PhD defence
-
Jacqueline VelFaculteit der Rechtsgeleerdheid
j.a.c.vel@law.leidenuniv.nl | 071 5272727
-
Rizal ShidiqFaculty of Humanities
a.r.shidiq@hum.leidenuniv.nl | 071 5278057
-
Selin TopelFaculty of Social and Behavioural Sciences
s.topel@fsw.leidenuniv.nl | 071 5272727
-
Boya LiFaculty of Social and Behavioural Sciences
b.li@fsw.leidenuniv.nl | 071 5272727
-
Marieke BosFaculty of Social and Behavioural Sciences
m.g.n.bos@fsw.leidenuniv.nl | 071 5276624
-
Jiemiao ChenFaculty of Social and Behavioural Sciences
j.chen@fsw.leidenuniv.nl | 071 5272727
-
Jochanan VeerbeekFaculty of Social and Behavioural Sciences
j.veerbeek@fsw.leidenuniv.nl | 071 5273399
-
A future with tailored therapy for patients with atherosclerosis
The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.
-
Alireza Mashaghi Tabaria.mashaghi.tabari@lacdr.leidenuniv.nl | 071 5274425